Tirzepatide (GLP-1 Analogue), 5mg

Tirzepatide is an investigational dual glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptor agonist developed for the treatment of type 2 diabetes and obesity, showing potential benefits in reducing blood sugar levels and body weight in preclinical and clinical studies. It acts by stimulating both GIP and GLP-1 receptors to improve glucose metabolism and regulate appetite.


SKU: NXT-GLP1-3M-1 Category: Tags: , , ,

Social Share: